Bupropion hydrochloride (Zyban): Stock issue resolved
GlaxoSmithKline has advised that the supply issue with Zyban (bupropion hydrochloride) is resolved, currently GSK has good stock holdings available and further deliveries are planned.
Affected product
Pharmacode: 2439743
Schedule listing(external link)
Alternative products
Varenicline (Champix) is unavailable due to manufacturing issue. Read the varenicline medicine notice
Nicotine patches, gum or lozenges are available and are fully funded to support people to stop smoking.
Schedule listing for nicotine products(external link)
Who to contact
If you have questions about supply of Zyban, please contact GSK:
- email: mel.customersupport@gsk.com
If you have questions about funding, contact Pharmac:
- email: enquiry@pharmac.govt.nz